Filing Details
- Accession Number:
- 0000721371-16-000273
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-10 17:24:01
- Reporting Period:
- 2016-08-08
- Filing Date:
- 2016-08-10
- Accepted Time:
- 2016-08-10 17:24:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
721371 | Cardinal Health Inc | CAH | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 310958666 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1425512 | S George Barrett | 7000 Cardinal Place Dublin OH 43017 | Chairman And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Acquisiton | 2016-08-08 | 20,428 | $30.94 | 510,762 | No | 4 | M | Direct | |
Common Shares | Disposition | 2016-08-08 | 20,428 | $83.75 | 490,334 | No | 4 | S | Direct | |
Common Shares | Acquisiton | 2016-08-09 | 129,818 | $30.94 | 620,152 | No | 4 | M | Direct | |
Common Shares | Disposition | 2016-08-09 | 129,818 | $83.76 | 490,334 | No | 4 | S | Direct | |
Common Shares | Acquisiton | 2016-08-10 | 99,754 | $30.94 | 590,088 | No | 4 | M | Direct | |
Common Shares | Disposition | 2016-08-10 | 99,754 | $83.44 | 490,334 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Common Shares | Disposition | 2016-08-08 | 20,428 | $0.00 | 20,428 | $30.94 |
Common Shares | Common Shares | Disposition | 2016-08-09 | 129,818 | $0.00 | 129,818 | $30.94 |
Common Shares | Common Shares | Disposition | 2016-08-10 | 99,754 | $0.00 | 99,754 | $30.94 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
665,561 | 2017-08-16 | No | 4 | M | Direct | |
535,743 | 2017-08-16 | No | 4 | M | Direct | |
435,989 | 2017-08-16 | No | 4 | M | Direct |
Footnotes
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.72 to $83.80, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 2 and 3 to this Form 4.
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.59 to $84.00, inclusive.
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.24 to $83.80, inclusive.
- The option, representing a right to purchase a total of 685,989 shares, vested and became exercisable in three equal annual installments beginning on August 16, 2011.
- This stock option expires on August 16, 2017. On August 8, 2016, the reporting person adopted a Rule 10b5-1 trading plan to sell the remaining 435,989 shares subject to this option in the open market at prevailing market prices between November 2016 and February 2017, subject to minimum price thresholds specified in the plan. These transactions will be disclosed publicly in Form 144 and Form 4 Filings with the SEC. The goal of the transactions reported in this Form 4 and the subsequent transactions under the Rule 10b5-1 plan is to fully exercise the stock option in several transactions over a period of approximately six months.